Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$18.24 +0.38 (+2.10%)
At close: Sep 29, 2026 · 4:00 PM EDT

Syndax Pharmaceuticals (SNDX) Share-based Compensation (2015 - 2026)

Updated

Syndax Pharmaceuticals' Share-based Compensation was $14.01 million in Q2 2026, up 1.6% from $13.79 million a year earlier and up 16.3% from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Share-based Compensation (2015 - 2026) Analysis & Trends

On a trailing twelve-month basis, Syndax Pharmaceuticals' Share-based Compensation was $49.4 million through Jun 30, 2026, up 2.1% year-over-year; for FY2025, it was $47.5 million, up 10.4% from FY2024.

  • Share-based Compensation has now increased for six consecutive years, with a five-year compound annual growth rate of 39.3% (FY2020 to FY2025).
  • In earlier years, Share-based Compensation was $43.03 million in FY2024 (+39.0%), $30.95 million in FY2023 (+93.2%), $16.02 million in FY2022 (+20.3%) and $13.32 million in FY2021 (+47.0%).
  • The Q2 2026 figure marks the highest quarterly Share-based Compensation in data going back to Q1 2015.
  • Compared with a year earlier, Share-based Compensation was higher in seven of the last eight quarters, with growth averaging 19.7%.
  • The best year-over-year quarter for Share-based Compensation over five years was Q2 2023 (growth of 104.8%); the worst was Q4 2025 (a decline of 8.5%).
  • Per Business Quant data, SNDX's Share-based Compensation in the three quarters before Q2 2026 was $12.05 million (Q1 2026), $11.25 million (Q4 2025) and $12.08 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Syndax Pharmaceuticals 1.59 Bn -137.74 Mn 69.58 Mn 14.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.01 Mn
Mar 31, 2026 12.05 Mn
Dec 31, 2025 11.25 Mn
Sep 30, 2025 12.08 Mn
Jun 30, 2025 13.79 Mn
Mar 31, 2025 10.38 Mn
Dec 31, 2024 12.30 Mn
Sep 30, 2024 11.93 Mn
Jun 30, 2024 9.90 Mn
Mar 31, 2024 8.90 Mn
Dec 31, 2023 8.33 Mn
Sep 30, 2023 8.32 Mn
Jun 30, 2023 8.07 Mn
Mar 31, 2023 6.24 Mn
Dec 31, 2022 4.24 Mn
Sep 30, 2022 4.36 Mn
Jun 30, 2022 3.94 Mn
Mar 31, 2022 3.48 Mn
Dec 31, 2021 3.93 Mn
Sep 30, 2021 3.38 Mn
API Access

Syndax Pharmaceuticals Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SNDX&period=max&api_key=YOUR_API_KEY